Business Context and Reporting Period
This Form 8-K was filed by Healthcare Trust of America, Inc. (NYSE: HTA) and its operating partnership, Healthcare Trust of America Holdings, LP, on November 29, 2019. The report details the entry into material definitive agreements regarding the company's equity capital programs.
Key Financial Metrics and Agreements
The filing announces the upsizing of the company's existing "at-the-market" equity sale program (the "Equity Program").
- Program Capacity: The aggregate offering price for Class A Common Stock under the amended program is up to $750,000,000, exclusive of shares previously issued.
- Agents: The program involves six agents: Wells Fargo Securities, BMO Capital Markets, Jefferies LLC, J.P. Morgan Securities, BofA Securities, and MUFG Securities Americas.
- Forward Sale Agreements: Concurrently, the company amended master forward confirmations with six forward purchasers to increase the amount issuable under these agreements.
- Use of Proceeds: Proceeds are intended for general corporate purposes, including working capital, share repurchases, real estate investment, and potentially paying outstanding long-term debt obligations.
The filing does not provide specific values for revenue, profit, cash flow, margins, or current debt levels.
Material Changes
The primary material change is the amendment of six existing equity distribution agreements and six master forward confirmations, originally dated December 28, 2018. These amendments increase the capacity of the equity offering program to $750 million.
Outlook, Risks, and Management Commentary
Management intends to utilize the proceeds from the Equity Program for flexible corporate purposes, including potential debt reduction and real estate investments. Sales are anticipated to be made primarily through "at-the-market" offerings on the New York Stock Exchange or through market makers, though negotiated transactions are also possible. The shares are offered under an effective Registration Statement on Form S-3ASR.
Investor Verification Checklist
- Verify the current number of shares previously issued under the Equity Program to calculate the total potential dilution.
- Review the full text of the EDA Amendments (Exhibits 1.1 through 1.6) and MFC Amendments (Exhibits 1.7 through 1.12) for specific terms and conditions.
- Assess the company's current debt load to evaluate the likelihood of proceeds being used for debt repayment versus new investments.
- Monitor future 8-K filings for actual sales executed under the amended program.